Patents by Inventor Esther Masih-Khan

Esther Masih-Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120149714
    Abstract: Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, are measured and identifications or adjustments may be made accordingly.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Inventors: Carla Heise, Esther Masih-Khan, Edward Moler, Michael Rowe, Keith Stewart, Suzanne Trudel
  • Patent number: 8158360
    Abstract: Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, are measured and identifications or adjustments may be made accordingly.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: April 17, 2012
    Assignee: Novartis AG
    Inventors: Carla Heise, Esther Masih-Khan, Edward Moler, Michael Rowe, Keith Stewart, Suzanne Trudel
  • Publication number: 20090048266
    Abstract: Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, are measured and identifications or adjustments may be made accordingly.
    Type: Application
    Filed: December 7, 2006
    Publication date: February 19, 2009
    Applicant: NOVARTS AG
    Inventors: Carla Heise, Esther Masih-Khan, Edward Moler, Michael Rowe, Keith Stewart, Suzanne Trudel